NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Allergy Therapeutics plc (LSE: AGY)
AGY Technical Analysis
5
As on 11th Jul 2023 AGY STOCK Price closed @ 1.70 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 28.16 & Strong Sell for SHORT-TERM with Stoploss of 33.81 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AGYSTOCK Price
Open | 1.48 | Change | Price | % |
High | 1.80 | 1 Day | 0.22 | 14.86 |
Low | 1.46 | 1 Week | 0.65 | 61.90 |
Close | 1.70 | 1 Month | -10.30 | -85.83 |
Volume | 2189840 | 1 Year | -28.55 | -94.38 |
52 Week High 38.50 | 52 Week Low 0.19 |
LSE UK Most Active Stocks
DKE | 0.15 | 0.00% |
NNN | 0.09 | 50.00% |
SYME | 0.10 | -9.09% |
DMTR | 0.03 | 0.00% |
PREM | 0.53 | 3.92% |
MCLS | 1.68 | 46.09% |
YGEN | 0.49 | 0.00% |
CLON | 0.11 | 0.00% |
VOD | 71.04 | 0.57% |
BOIL | 0.10 | 0.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
AGY Daily Charts |
AGY Intraday Charts |
Whats New @ Bazaartrend |
AGY Free Analysis |
|
AGY Important Levels Intraday
RESISTANCE | 2.36 |
RESISTANCE | 2.15 |
RESISTANCE | 2.02 |
RESISTANCE | 1.89 |
SUPPORT | 1.51 |
SUPPORT | 1.38 |
SUPPORT | 1.25 |
SUPPORT | 1.04 |
AGY Forecast May 2024
4th UP Forecast | 76.51 |
3rd UP Forecast | 52.52 |
2nd UP Forecast | 37.69 |
1st UP Forecast | 22.86 |
1st DOWN Forecast | -19.46 |
2nd DOWN Forecast | -34.29 |
3rd DOWN Forecast | -49.12 |
4th DOWN Forecast | -73.11 |
AGY Weekly Forecast
4th UP Forecast | 9.50 |
3rd UP Forecast | 7.00 |
2nd UP Forecast | 5.45 |
1st UP Forecast | 3.91 |
1st DOWN Forecast | -0.51 |
2nd DOWN Forecast | -2.05 |
3rd DOWN Forecast | -3.60 |
4th DOWN Forecast | -6.10 |
AGY Forecast2024
4th UP Forecast | 79.4 |
3rd UP Forecast | 54.48 |
2nd UP Forecast | 39.08 |
1st UP Forecast | 23.67 |
1st DOWN Forecast | -20.27 |
2nd DOWN Forecast | -35.68 |
3rd DOWN Forecast | -51.08 |
4th DOWN Forecast | -76 |
Allergy Therapeutics plc ( LSE UK Symbol : AGY )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AGY Other Details
Segment | EQ | |
Market Capital | 226234144.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
AGY Address
AGY Latest News
AGY Business Profile
Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom. Address: Dominion Way, Worthing, United Kingdom, BN14 8SA
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service